Authors: Villalona-Calero, MA Blum, JL Jones, SE Diab, S Elledge, R Khoury, P Von Hoff, D Kraynak, M Moczygemba, J Kromelis, P Griffin, T Rowinsky, EK

Citation: Ma. Villalona-calero et al., A phase I and pharmacologic study of capecitabine and paclitaxel in breastcancer patients, ANN ONCOL, 12(5), 2001, pp. 605-614

Authors: Blum, JL Dieras, V Lo Russo, PM Horton, J Rutman, O Buzdar, A Osterwalder, B

Citation: Jl. Blum et al., Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients, CANCER, 92(7), 2001, pp. 1759-1768

Authors: Wistuba, II Tomlinson, GE Behrens, C Virmani, A Geradts, J Blum, JL Minna, JD Gazdar, AF

Citation: Ii. Wistuba et al., Two identical triplet sisters carrying a germline BRCAI gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome, GENE CHROM, 28(4), 2000, pp. 359-369

Authors: Blum, JL Jones, SE Buzdar, AU LoRusso, PM Kuter, I Vogel, C Osterwalder, B Burger, HU Brown, CS Griffin, T

Citation: Jl. Blum et al., Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer, J CL ONCOL, 17(2), 1999, pp. 485-493

Authors: Blum, JL

Citation: Jl. Blum, Xeloda (R) in the treatment of metastatic breast cancer, ONCOL-BASEL, 57, 1999, pp. 16-20

Authors: Blum, JL

Citation: Jl. Blum, Capecitabine - A viewpoint, DRUGS, 58(1), 1999, pp. 77-77